Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 7/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 5/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CSF1R | P07333 | 1/20 | 0.37 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.37 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.36 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6323212 | 0.99 | F10 (0.45) | F10PRSS1HPGDALDH1A1LMNA | |
| SCHEMBL6331777 | 0.85 | F10 (0.48) | F10PRSS1HPGDALDH1A1LMNA | |
| SCHEMBL2998619 | 0.85 | F10 (0.46) | F10PRSS1HPGDALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL6326771 | 0.84 | F10 (0.45) | F10PRSS1HPGDALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL6332596 | 0.83 | HPGD (0.43) | F10PRSS1HPGDALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL6325009 | 0.79 | HPGD (0.43) | F10PRSS1HPGDALDH1A1LMNA | |
| SCHEMBL6323093 | 0.77 | F10 (0.40) | F10PRSS1HPGDALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL6325008 | 0.77 | F10 (0.40) | F10PRSS1HPGDALDH1A1CSF1R | |
| SCHEMBL6326757 | 0.76 | HPGD (0.46) | F10PRSS1HPGDALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL6324262 | 0.76 | PDE5A (0.40) | F10PRSS1HPGDALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050107409-A1 | Aromatic bicyclic compounds, preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-05-19 | — | — | US | disclosed |
| WO-2004080970-A1 | NOVEL BICYCLIC AROMATIC COMPOUNDS, THE PRODUCTION AND USE THEREOF IN THE FORM OF DRUGS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050107409-A1 | Aromatic bicyclic compounds, preparation thereof and their use as pharmaceutical compositions | F12, F2, F11 | F10 11/4885PRSS1 182/4885HPGD 1428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.